![Yu Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yu Wang
Technik-/Wissenschafts-/F&E-Leiter bei
GENFLEET THERAPEUTICS (SHANGHAI) INC.
Profil
Yu Wang is currently the Chief Medical Officer at Genfleet Therapeutics (Shanghai), Inc. and Abbisko Therapeutics Co., Ltd. He previously worked as the Director-Associate Medical at Eli Lilly Asia, Inc. from 2007 to 2010, Director-Medical at GlaxoSmithKline (China) Investment Co., Ltd. from 2010 to 2012, Director-Clinical Research at Sanofi (China) Investment Co. Ltd. from 2012 to 2013, Senior Research Member at Shanghai Sunway Biotech Co., Ltd. from 2005 to 2007, Partner at Zenrhyme Consulting Services Co. Ltd. from 2018 to 2020, and Chief Scientist Officer at Beijing Panacro Pharmaceutical Technology Co. Ltd. from 2016 to 2017.
Dr. Wang obtained a doctorate degree from Shanghai Medical College of Fudan University in 2000 and an undergraduate degree from Tongji Medical College of Huazhong University of Sci & Tech in 1995.
Aktive Positionen von Yu Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| GENFLEET THERAPEUTICS (SHANGHAI) INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
Ehemalige bekannte Positionen von Yu Wang
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi (China) Investment Co. Ltd.
 Sanofi (China) Investment Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Corporate Officer/Principal | 01.09.2013 |
GlaxoSmithKline (China) Investment Co., Ltd.
 GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and wholesales pharmaceuticals, vaccines, and consumer healthcare products | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2012 |
Eli Lilly Asia, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2010 |
Ausbildung von Yu Wang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Shanghai Sunway Biotech Co., Ltd.
 Shanghai Sunway Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biomedical technology enterprise that develops and commercializes drugs for gene and immunotherapy | Health Technology |
Shanghai Medical College of Fudan University
 Shanghai Medical College of Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly Asia, Inc. | |
Tongji Medical College of Huazhong University of Sci & Tech
 Tongji Medical College of Huazhong University of Sci & Tech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
GlaxoSmithKline (China) Investment Co., Ltd.
GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and wholesales pharmaceuticals, vaccines, and consumer healthcare products | Health Technology |
Sanofi (China) Investment Co. Ltd.
Sanofi (China) Investment Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Health Technology |
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Health Technology |
